These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3102719)

  • 1. Intranasal administration of peptides: nasal deposition, biological response, and absorption of desmopressin.
    Harris AS; Nilsson IM; Wagner ZG; Alkner U
    J Pharm Sci; 1986 Nov; 75(11):1085-8. PubMed ID: 3102719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of concentration and volume on nasal bioavailability and biological response to desmopressin.
    Harris AS; Ohlin M; Lethagen S; Nilsson IM
    J Pharm Sci; 1988 Apr; 77(4):337-9. PubMed ID: 3379594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of viscosity on the pharmacokinetics and biological response to intranasal desmopressin.
    Harris AS; Ohlin M; Svensson E; Lethagen S; Nilsson IM
    J Pharm Sci; 1989 Jun; 78(6):470-1. PubMed ID: 2760821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nasal administration of desmopressin by spray and drops.
    Harris AS; Hedner P; Vilhardt H
    J Pharm Pharmacol; 1987 Nov; 39(11):932-4. PubMed ID: 2892918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal and intravenous administration of desmopressin: effect on F VIII/vWF, pharmacokinetics and reproducibility.
    Lethagen S; Harris AS; Sjörin E; Nilsson IM
    Thromb Haemost; 1987 Dec; 58(4):1033-6. PubMed ID: 3127915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of viscosity on particle size, deposition, and clearance of nasal delivery systems containing desmopressin.
    Harris AS; Svensson E; Wagner ZG; Lethagen S; Nilsson IM
    J Pharm Sci; 1988 May; 77(5):405-8. PubMed ID: 3411462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nasal spray desmopressin (DDAVP) for mild hemophilia A and von Willebrand disease.
    Rose EH; Aledort LM
    Ann Intern Med; 1991 Apr; 114(7):563-8. PubMed ID: 1900403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A replicate study design for testing bioequivalence: a case study on two desmopressin nasal spray preparations.
    Joukhadar C; Schenk B; Kaehler ST; Kollenz CJ; Bauer P; Müller M; Eichler HG
    Eur J Clin Pharmacol; 2003 Nov; 59(8-9):631-6. PubMed ID: 14564429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of intranasal histamine on nasal mucosal blood flow and the antidiuretic activity of desmopressin.
    Olanoff LS; Titus CR; Shea MS; Gibson RE; Brooks CD
    J Clin Invest; 1987 Sep; 80(3):890-5. PubMed ID: 3624491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic and Pharmacodynamic Properties of a Micro-Dose Nasal Spray Formulation of Desmopressin (AV002) in Healthy Water-Loaded Subjects.
    Andersson KE; Longstreth J; Brucker BM; Campeau L; Cheng L; Francis L; Fein S
    Pharm Res; 2019 Apr; 36(6):92. PubMed ID: 31037429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The duration of antidiuretic response of two desmopressin nasal sprays.
    Eller N; Kollenz CJ; Bauer P; Hitzenberger G
    Int J Clin Pharmacol Ther; 1998 Sep; 36(9):494-500. PubMed ID: 9760011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of pharmacodynamics and bioavailability of 2 different desmopressin nasal sprays.
    Eller N; Kollenz CJ; Hitzenberger G
    Int J Clin Pharmacol Ther; 1998 Mar; 36(3):139-45. PubMed ID: 9562229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nasal absorption of desmopressin in rats and sheep. Effect of a bioadhesive microsphere delivery system.
    Critchley H; Davis SS; Farraj NF; Illum L
    J Pharm Pharmacol; 1994 Aug; 46(8):651-6. PubMed ID: 7815278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal drug delivery by spray and drops.
    Hardy JG; Lee SW; Wilson CG
    J Pharm Pharmacol; 1985 May; 37(5):294-7. PubMed ID: 2862235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of desmopressin on hemostatic parameters in the normal dog.
    Johnstone IB; Crane S
    Can J Vet Res; 1986 Apr; 50(2):265-71. PubMed ID: 3093039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Desmopressin (DDAVP) for treatment of disorders of hemostasis.
    Mannucci PM
    Prog Hemost Thromb; 1986; 8():19-45. PubMed ID: 3104987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in factor VIII: coagulant activity and von Willebrand factor antigen concentration after subcutaneous injection of desmopressin in dogs with mild hemophilia A.
    Mansell PD; Parry BW
    J Vet Intern Med; 1991; 5(3):191-4. PubMed ID: 1920255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the degradation of desamino1,D-arginine8-vasopressin by nasal mucosa.
    Jönsson K; Alfredsson K; Söderberg-Ahlm C; Critchley H; Broeders A; Ohlin M
    Acta Endocrinol (Copenh); 1992 Jul; 127(1):27-32. PubMed ID: 1519419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation of desmopressin-containing liposomes for intranasal delivery.
    Law SL; Huang KJ; Chou HY
    J Control Release; 2001 Feb; 70(3):375-82. PubMed ID: 11182207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desmopressin for the treatment of haemophilia.
    Castaman G
    Haemophilia; 2008 Jan; 14 Suppl 1():15-20. PubMed ID: 18173690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.